Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On the 11th February the MsC IHTM students visited the House of Parliament and presented their policy briefs in the House of Lords.

Group photo of the MSc IHTM team in front of the Houses of Parliament
Photo of the 2019-2020 MSc IHTM cohort visiting to the Houses of Parliament

The five briefs focused on a variety of themes:

  • providing better universal healthcare by strengthening better primary health care and improving digital health tech
  • develop affordable diagnostic tools and medicines for neglected tropical diseases
  • benefits and risks of multi-sectoral collaboration in the funding of neglected tropical diseases programmes
  • benefits of investing in programmes that improve child health through immunisation & nutrition
  • potential collaboration between UK and Bangladeshi governments to ensure the hepatitis C crisis amongst the Rohingya refugees in Cox’s Bazar is contained and extinguished

The presentations were very well received by our host Lord Tress, Lord Collins of Highbury and Mr Jeremy Lefroy (former chair of the APPG NTDs).

Similar stories

Systematic review identifies research gaps for Chagas disease

A new, large-scale systematic review published in PLOS Neglected Tropical Diseases has identified clear, significant research gaps in the diagnosis and treatment of Chagas disease. The paper also highlights significant differences in study design, diagnostic methods, duration of follow-up, and the timing of outcome assessment used by investigators even in the last decade.

The scale of the problem of visceral leishmaniasis in pregnancy is underestimated

Despite the limitations and paucity of data, the most comprehensive review of visceral leishmaniasis to date in pregnant women and vertical transmission of leishmaniasis has confirmed that liposomal amphotericin B is the safest treatment option and it is critical to ensure access to this.

Delays in presentation of intussusception and development of gangrene in Zimbabwe

Student Dennis Mazingi (cohort 2020-2021) co-authored this paper focused on the importance of a prompt diagnosis and treatment of intussusception in Zimbabwe. Their findings highlight the need to improve early diagnosis of intussusception and prompt referral of patients for treatment.

RECOVERY Trial announced as overall winner of Best COVID-19 Response Project Award in the UK

The RECOVERY Trial has won the Project Management Institute’s Special Covid-19 UK Response Project Award. The award specifically recognised RECOVERY’s work to investigate whether the cheap steroid dexamethasone was an effective treatment for patients hospitalised with severe COVID-19.

ISARIC COVID-19 clinical database passes ½ million patient records mark

COVID-19 has exposed our vulnerability to pandemic infections and shown what works, and what does not. It has tested the effectiveness of the Oxford-based global, open-source, collaborative approach set up 10 years ago to prevent illness and deaths from infectious disease outbreaks: ISARIC, the International Severe Acute Respiratory and Emerging Infection Consortium.

RECOVERY Trial named joint winner of HDR UK’s Impact of the Year Award

The RECOVERY trial has been jointly awarded Health Data Research UK’s 2021 Impact of the Year Award. This award is open to projects which had effectively used health data to improve people’s lives, including through clinical practice, policy, software, algorithms, or publications. The award was presented by James O’Shaughnessy at HDR UK’s online Annual Scientific Conference: Data Insights in a Pandemic.